liveBook · Manning

ATP-binding pocket

As explained in Build AI Drug Discovery Pipelines

An ATP-binding pocket is the kinase binding-site cavity where adenosine triphosphate binds during catalysis.

An ATP-binding pocket is the kinase binding-site cavity where ATP binds during catalysis. Because this site is highly conserved across kinases, inhibitors can bind unintended family members, making affinity and selectivity central drug-discovery concerns. section 8.1.1 section 13.3.1

The pocket matters in kinase drug discovery because it:

  • Provides a well-defined site for competitive small-molecule inhibitors. section 13.3.1
  • Creates an affinity–selectivity trade-off: conserved binding features can produce off-target activity across the kinase family. section 8.1.1
  • Makes sequence differences within the pocket useful for designing more selective inhibitors. section 13.3.1

TNIK as a selectivity case

For idiopathic pulmonary fibrosis research, TNIK was considered druggable because its kinase domain offered an ATP-binding pocket. Sequence differences from other kinases suggested that selective inhibition might be achievable, reducing off-target risk even though no selective small molecule or ligand-bound crystal structure was available. section 13.3.1

Figure 8.2 Map of human protein kinases, i.e., the Manning kinome tree, clustered based on sequence similarity into eight major groups [3].

Use the kinome tree to place ATP-pocket targeting within the broader family of human kinases and its uneven landscape of approved drugs. section 8.1.1

How Build AI Drug Discovery Pipelines covers it

How deep it goes
Defines the pocket as a competitive-inhibitor site and links conservation and sequence variation to off-target risk and selectivity.
Examples
Uses the TNIK kinase domain and the human kinome tree to illustrate druggability, pocket variation, and family-wide selectivity.
What you can do after
Evaluate kinase targets by considering ATP-pocket definition, conservation, sequence differences, and computational selectivity opportunities.
How it connects
Connects ATP-binding pockets with kinases, kinase inhibitors, druggability, competitive inhibition, selectivity, and off-target effects.

Related concepts

This explainer was generated by Manning's knowledge graph from the text of Build AI Drug Discovery Pipelines. The section links point to the parts of the book it draws on.